NuvOx Completes Construction of Expanded Manufacturing Facility

NuvOx Pharma
Apr 30, 2021
1 min read

A new GMP production facility including an ISO 5 cleanroom has been constructed and has initiated operations. Click here to read more...

Recent Posts

See All

NuvOx and Dr. Pavani Chalasani Announce acceptance of abstracts in Triple Negative Breast Cancer at 2 prestigious conventions - “Novel Oxygen Therapeutic Shows Promise in Boosting Immunotherapy”

Tucson, AZ – November 24, 2025 – Today NuvOx Therapeutics, Inc. (“NuvOx”) along with Dr. Pavani Chalasani of George Washington University announced the acceptance of abstracts in Triple Negative Bre

NuvOx Therapeutics Highlights Progress of RESTORE Phase II Trial of NanO₂™ in Newly Diagnosed Glioblastoma at the Society for Neuro-Oncology (SNO) 2025 Annual Meeting

Tucson, Arizona — November 12, 2025 — NuvOx Therapeutics, Inc. (“NuvOx”), a clinical-stage biotechnology company developing oxygen therapeutics to enhance the efficacy of cancer treatment, today annou

NuvOx Therapeutics Announces Positive Results from First Cohort of EXTEND-1b Trial of NanO₂™ in Patients with Respiratory Distress

Tucson, Arizona — November 6, 2025 — NuvOx Therapeutics (“NuvOx”), a clinical-stage biotechnology company developing oxygen therapeutics to treat life-threatening hypoxemic conditions, announced encou

Comments